Emerging opportunities in the C5 inhibitor market include advances in biosuperiors and biosimilars, targeting a range of C5-mediated diseases such as PNH and aHUS. Innovations focus on enhancing ...
Bank of America Global Healthcare Conference 2026 May 13, 2026 2:20 PM EDTCompany ParticipantsDouglas Love - CEO, President ...
Can a handful of atoms outperform a much larger digital neural network on a real-world task? The answer may be yes. In a study published in Physical Review Letters, a team led by Prof. Peng Xinhua and ...
5 Semmelweis University, Department of Internal Medicine and Haematology, Budapest, Hungary 6 Semmelweis University-Eötvös Loránd Research Network (Office for Supported Research Groups), Research ...
Novo Nordisk is paying $240 million for global rights to a Phase 3-ready drug from Omeros that could rival immune disorder medications currently available from companies such as AstraZeneca, Novartis, ...
Among people with sickle cell disease—an inherited blood disorder—acute chest syndrome (ACS) is the leading cause of death. The condition is the result of red blood cells becoming stiff, sticky, and ...
Aditi Nikhil Deshpande, a senior at Amador Valley High School in Pleasanton, was recently named one of the top 300 finalists by the Society for Science for her research on early detection of ...
Our immune system is armed with an array of defenses designed to detect and eliminate harmful threats. One of its most powerful defense mechanisms is the complement system-a group of proteins that ...
The original discovery of the complement system focused on its ability to complement the actions of antibody in host defense and bacterial killing. As part of innate immunity, the complement system ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results